The endocrinology of aging.

[1]  D. Leroith,et al.  Role of the IGF-I receptor in mutagenesis and tumor promotion. , 1997, Journal of Endocrinology.

[2]  S. Bhasin,et al.  Emerging Issues in Androgen Replacement Therapy , 1997 .

[3]  D. Schade,et al.  Recombinant Human Growth Hormone, Insulin-like Growth Factor 1, and Combination Therapy in AIDS-Associated Wasting , 1996, Annals of Internal Medicine.

[4]  E. van Cauter,et al.  Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. , 1996, The Journal of clinical endocrinology and metabolism.

[5]  L. Mattsson,et al.  Use of hormone replacement therapy , 1996, The Lancet.

[6]  A. Skolnick.  Scientific verdict still out on DHEA. , 1996, JAMA.

[7]  K. Nair,et al.  Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.

[8]  Yaakov Stern,et al.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease , 1996, The Lancet.

[9]  Patrick R. Griffin,et al.  A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release , 1996, Science.

[10]  J. Manson,et al.  Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. , 1996, The New England journal of medicine.

[11]  P. Saenger.  Oral growth hormone secretagogues--better than Alice in Wonderland's growth elixir? , 1996, The Journal of clinical endocrinology and metabolism.

[12]  K. Krajnak,et al.  Menopause: The Aging of Multiple Pacemakers , 1996, Science.

[13]  N. Ancy,et al.  The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. , 1996 .

[14]  R. Santen.  Long-term tamoxifen therapy: can an antagonist become an agonist? , 1996, The Journal of clinical endocrinology and metabolism.

[15]  C. Arnaud,et al.  A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  M. Sato,et al.  Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance. , 1996, Endocrinology.

[17]  M. Schambelan,et al.  Growth Hormone Replacement in Healthy Older Men Improves Body Composition but Not Functional Ability , 1996, Annals of Internal Medicine.

[18]  D. Grainger,et al.  Tamoxifen: Teaching an old drug new tricks? , 1996, Nature Medicine.

[19]  W. Bremner,et al.  Androgens in men--uses and abuses. , 1996, The New England journal of medicine.

[20]  G. Ravaglia,et al.  The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. , 1996, The Journal of clinical endocrinology and metabolism.

[21]  S. Shalet,et al.  Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. , 1996, The Journal of clinical endocrinology and metabolism.

[22]  S. Pong,et al.  Identification of a new G-protein-linked receptor for growth hormone secretagogues. , 1996, Molecular endocrinology.

[23]  K. Korach,et al.  Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. , 1996, Recent progress in hormone research.

[24]  S. Yen,et al.  Replacement of DHEA in Aging Men and Women , 1995, Annals of the New York Academy of Sciences.

[25]  C. Grunfeld,et al.  Insulin‐like Growth Factor 1 and Functional Status in Healthy Older Men , 1995, Journal of the American Geriatrics Society.

[26]  I. Reid,et al.  The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women. , 1995, The American journal of medicine.

[27]  C. Franceschi,et al.  The aging thyroid. , 1995, Endocrine reviews.

[28]  E. Barrett-Connor,et al.  The Epidemiology of DHEAS and Cardiovascular Disease , 1995, Annals of the New York Academy of Sciences.

[29]  J. Simard,et al.  DHEA and Peripheral Androgen and Estrogen Formation: Intracrinology , 1995, Annals of the New York Academy of Sciences.

[30]  G A Colditz,et al.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. , 1995, The New England journal of medicine.

[31]  J. Pike,et al.  Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. , 1995, Molecular endocrinology.

[32]  J. Herbert.  The age of dehydroepiandrosterone , 1995, The Lancet.

[33]  M. Korbonits,et al.  Growth hormone-releasing peptide and its analogues Novel stimuli to growth hormone release , 1995, Trends in Endocrinology & Metabolism.

[34]  V. Klauss,et al.  Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. , 1995, The Journal of clinical endocrinology and metabolism.

[35]  Warszawski Uniwersytet Medyczny,et al.  Diabetes care , 2019, Health at a Glance.

[36]  J. S. Tenover.  Androgen administration to aging men. , 1994, Endocrinology and metabolism clinics of North America.

[37]  S B Roberts,et al.  Exercise training and nutritional supplementation for physical frailty in very elderly people. , 1994, The New England journal of medicine.

[38]  A. Morales.  Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age [published erratum appears in J Clin Endocrinol Metab 1995 Sep;80(9):2799] , 1994 .

[39]  S. Yen,et al.  Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. , 1994, The Journal of clinical endocrinology and metabolism.

[40]  D. Williams,et al.  Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. , 1994, The Journal of clinical investigation.

[41]  L. Rutqvist,et al.  Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group. , 1993, Journal of the National Cancer Institute.

[42]  M. Blackman,et al.  Human growth hormone and human aging. , 1993, Endocrine reviews.

[43]  Caroline S. Fox,et al.  Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women , 1992, Annals of Internal Medicine.

[44]  J. S. Tenover,et al.  Effects of testosterone supplementation in the aging male. , 1992, The Journal of clinical endocrinology and metabolism.

[45]  M. Kosorok,et al.  Restricted activity days among older adults. , 1992, American journal of public health.

[46]  M. Blackman,et al.  Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. , 1992, The Journal of clinical endocrinology and metabolism.

[47]  W. Rakowski,et al.  The association of physical activity with mortality among older adults in the Longitudinal Study of Aging (1984-1988). , 1992, Journal of gerontology.

[48]  C. Franceschi,et al.  Thyroid and other organ-specific autoantibodies in healthy ceritenarians , 1992, The Lancet.

[49]  R B Mazess,et al.  Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. , 1992, The New England journal of medicine.

[50]  J. Morley,et al.  Endocrinology and Metabolism in the Elderly , 1992 .

[51]  V. Ernster,et al.  Invited Commentary: Does Postmenopausal Hormone Therapy Cause Breast Cancer? , 1991 .

[52]  A. Vermeulen.  Clinical review 24: Androgens in the aging male. , 1991, The Journal of clinical endocrinology and metabolism.

[53]  E. Poehlman,et al.  Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. , 1990, The Journal of clinical endocrinology and metabolism.

[54]  J. Studd,et al.  Can the withdrawal bleed following oestrogen replacement therapy be avoided? , 1990, British journal of obstetrics and gynaecology.

[55]  M. Harris.  Epidemiology of diabetes mellitus among the elderly in the United States. , 1990, Clinics in geriatric medicine.

[56]  D. Rudman,et al.  Effects of human growth hormone in men over 60 years old. , 1990, The New England journal of medicine.

[57]  J. Tobin,et al.  The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. , 1990, Journal of gerontology.

[58]  Hsieh Cy,et al.  Reliability of manual muscle testing with a computerized dynamometer. , 1990, Journal of manipulative and physiological therapeutics.

[59]  P. Sönksen,et al.  The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. , 1989, The New England journal of medicine.

[60]  D. Wilmore,et al.  Low‐Dose Growth Hormone and Hypocaloric Nutrition Attenuate the Protein‐Catabolic Response After Major Operation , 1989, Annals of surgery.

[61]  M. Tinetti,et al.  Risk factors for falls among elderly persons living in the community. , 1988, The New England journal of medicine.

[62]  J. Morley,et al.  Endocrinology in aging. , 1988, Disease-a-month : DM.

[63]  M. Blackman.  Pituitary hormones and aging. , 1987, Endocrinology and metabolism clinics of North America.

[64]  J. Rowe,et al.  Human aging: usual and successful. , 1987, Science.

[65]  M. Tinetti.  Factors Associated with Serious Injury During Falls by Ambulatory Nursing Home Residents , 1987, Journal of the American Geriatrics Society.

[66]  Parsons Vl,et al.  Current estimates from the National Health Interview Survey. United States, 1985. , 1986, Vital and health statistics. Series 10, Data from the National Health Survey.

[67]  V. Parsons,et al.  Current estimates from the National Health Interview Survey. United States, 1985. , 1986, Vital and health statistics. Series 10, Data from the National Health Survey.

[68]  D. Rudman.  Growth Hormone, Body Composition, and Aging , 1985, Journal of the American Geriatrics Society.

[69]  J. Brody.  Prospects for an ageing population , 1985, Nature.

[70]  D. Doniach,et al.  Autoantibodies in highly aged humans , 1984, Mechanisms of Ageing and Development.

[71]  J. Olefsky,et al.  The physiological significance of the glucose intolerance of aging. , 1984, Journal of gerontology.

[72]  F. Momany,et al.  On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. , 1984, Endocrinology.

[73]  S. Gambert,et al.  Endocrinology and Metabolism in the Elderly , 1983 .

[74]  D. Prudham,et al.  Factors associated with falls in the elderly: a community study. , 1981, Age and ageing.

[75]  J F Fries,et al.  Aging, natural death, and the compression of morbidity. , 1980, The New England journal of medicine.

[76]  S. Korenman,et al.  Endocrine aspects of aging. , 1980, Annals of internal medicine.

[77]  M. Davidson,et al.  The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. , 1979, Metabolism: clinical and experimental.

[78]  V. P. Butler,et al.  Progressive decrease in serum triiodothyronine concentrations with human aging: radioimmunoassay following extraction of serum. , 1973, The Journal of clinical endocrinology and metabolism.

[79]  C. Pearlman,et al.  Frequency of intercourse in men. , 1972, The Journal of urology.

[80]  R. Stephenson.  A and V , 1962, The British journal of ophthalmology.